Found "Early HTA": 383 results
Health Technology Assessment Development in Lao PDR
Together with the Mahidol Oxford Tropical Medicine Research Unit (MORU), HITAP has been engaged in assisting with building technical capacity for HTA and more broadly, evidence-informed decisions for health care in Laos since 2019. Towards this objective, HITAP hosted researchers from University of Health Sciences (UHS) and Lao-Oxford-Mahosot Hospi
Health Technology Assessment Development in Philippines
Since 2013, HITAP has supported HTA development and capacity building in the Philippines. In 2019, the Philippines mandated the provision of universal health coverage to all Filipinos. To support the decision-making for this promising undertaking, the partners continue their collaboration through technical assisatance on national HTA guidelines, on
Knowledge Sharing in the Time of COVID-19
During this period of rapid change and transition with the COVID-19 pandemic, the use of evidence is increasingly important. A webinar series and corresponding toolkit can support country partners and researchers to continue growing in knowledge and understanding in this field despite the restrictions on travel and face-to-face support. The webinar
Landscape Analysis of HTA capacity in the ASEAN
The Association of Southeast Asian Nations (ASEAN) region is characterised by diversity. Progress towards Universal Health Coverage (UHC) and institutionalisation of priority setting through Health Technology Assessment (HTA) is varied and is dependent on several country-specific factors such as the proportion of public investment in health, politi
SAPPHIRE
HITAP, under the leadership of the National Health Foundation (NHF), Thailand, is partnering with the Saw Swee Hock School of Public Health (SSHSPH), National University of Singapore (NUS) and the Mathematical/Economic Modelling Department (MAEMOD) at the Mahidol Oxford Tropical Medicine Research Unit (MORU) as part of the Asia HTA Consortium
Navigating the landscape of Digital Health
To understand the digital health landscape in different countries from national strategy and regulation to HTA evaluation, adoption, and challenges. The objective is to use this information to better inform digital health policy in Thailand as well as to create a reference case to conduct HTA for digital health technologies.
HTA for biologics for non-SJIA
Conducting economic evaluation and budget impact of biologic agents as 2nd-line treatment options for non-systemic juvenile idiopathic arthritis patients who are refractory to 1st-line treatment.Documents
HTA of COVID-19 vaccines in the Philippines
Adapting a dynamic transmission model developed by National University of Singapore to the Philippines context, in order to address policy questions around COVID-19 vaccine choice, target population for booster doses, and the impact of social gatherings on COVID-19 spread.
HTA of COVID-19 vaccines in Thailand
To calibrate the Covid M SEIR model to Thailand and to build capacity to use the model to address policy questions in Thailand. This project will address COVID-19 vaccination policy questions, such as frequency and target population for booster doses, as well as development of web-based applications to communicate the results to policymakers and ot
Bhutan
Building technical capacity as well as providing technical support to conduct HTA related study and institutionalise HTA process in Bhutan.
10 / Page